Health News

Early Weaning in HIV Positive Feeding?
Breastfeeding may be seen as optional in the Western world. But in other places, it may be necessary for the survival of the child, even if the mother has HIV.
Alternative Routes to Lower Blood Pressure
Meditation may never replace medication when it comes to effectively treating high blood pressure, but alternative treatments can support proven hypertension therapies.
Ladies Not Taking Brittle Bone Rx
Many women haven’t been taking their prescriptions to treat bone loss from their osteoporosis. Money may not have anything to do with the lack of following doctor’s orders.
OTC Painkillers Aren’t Marathon Candy
Just because a painkiller can be bought over-the-counter doesn’t mean that it can't hurt the body. Marathon runners that take preventive painkillers may be at risk for bad reactions.
Nora Apothecary & Alternative Therapies Announces Recall of Compound Products
Nora Apothecary & Alternative Therapies today announced a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that have not reached the expiration date listed on the product.
Preserving Breast Beauty After Cancer
Radiation therapy is commonly given after breast cancer surgery. The intense energy kills remaining cancer cells. The therapy can also change the look, feel and size of the treated breast.
Other Cancers After Skin Cancer
Skin cancers are far and away the most common form of cancer in the United States. More than two million Americans are diagnosed with some form of the disease each year.
Coping with Traumatic Events
America had a rough time last week. The Boston bombings, the explosion in West, Texas, and the Boston manhunt have been difficult for many to cope with.
See It, Maybe Eat It
Finding the calorie count on fast food and restaurant menus is easier now than ever before. But what if the menu also included the time it takes to burn those calories?
New Drug Application for Amitiza Approved
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. announced today that the FDA has approved Sucampo’s supplemental new drug application (sNDA) for AMITIZA ® (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.